학술논문
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
Document Type
Journal
Author
Talbot, Alexis; Bobin, Arthur; Tabone, Lea; Lambert, Jerome; Boccaccio, Catherine; Deal, Cecile; Petillon, Marie-Odile; Allangba, Olivier; Agape, Philippe; Arnautou, Pierre; Belkhir, Rakiba; Cailleres, Sylvie; Chaoui, Driss; Chretien, Marie-Lorraine; Decaux, Olivier; Schulmann, Samantha; Frenzel, Laurent; Gastaud, Lauris; Huart, Antoine; Hulin, Cyrille; Karlin, Lionel; Laribi, Kamel; Le Calloch, Ronan; Lenain, Pascal; Macro, Margaret; Manier, Salomon; Montes, Lydia; Moreau, Stephane; Moreau, Philippe; Morel, Veronique; Norwood, James; Piocelle, Frederique Orsini; Perrot, Aurore; Pica, Gian Matteo; Rey, Philippe; Schmitt, Anna; Stoppa, Anne-Marie; Tiab, Mourad; Touzeau, Cyrille; Vidal, Valerie; Vignon, Marguerite; Vincent, Laure; Van De Wyngaert, Zoe; Zarnitsky, Charles; Kerbouche, Naima; Paka, Prani; Leleu, Xavier; Arnulf, Bertrand; Avet-Loiseau, Herve
Source
Subject
Language
English
ISSN
15928721